Welcome to our dedicated page for Moolec Science news (Ticker: MLEC), a resource for investors and traders seeking the latest updates and insights on Moolec Science stock.
Moolec Science SA (NASDAQ: MLEC) generates news at the intersection of food-tech, life sciences, and agricultural biotechnology. The company regularly issues updates on how it engineers plants and microbes to produce animal proteins, nutritional oils, bioactive compounds, and biological inputs for regenerative agriculture through its Molecular Farming and precision fermentation platforms.
News about Moolec often covers progress in its key ingredient programs, such as its GLASO safflower technology enriched in gamma-linolenic acid and its Piggy Sooy™ soybean platform engineered to express porcine hemeproteins. Press releases have highlighted regulatory approvals, including feed and food approval for GLASO technology in Argentina and U.S. regulatory milestones for Piggy Sooy™, as well as large-scale agricultural campaigns and acreage expansion in the United States.
Investors and industry observers can also find coverage of Moolec’s corporate and strategic developments. Recent announcements include the closing of a strategic business combination with Bioceres Group Limited, Gentle Technologies Corp, and Nutrecon LLC, which expanded Moolec’s activities into ag-biologicals, biomaterials, and R&D services. The company also reports on the integration of Mycofood™, its fungal-based alternative protein platform produced via precision fermentation.
Moolec’s news flow additionally includes capital markets and compliance updates, such as Nasdaq determination letters related to minimum bid price, stockholders’ equity, and filing timelines, as well as share consolidations and reverse stock splits intended to support continued listing on the Nasdaq Capital Market. For readers tracking MLEC, this news page provides a centralized view of operational milestones, regulatory events, strategic transactions, and listing-related actions that shape the company’s trajectory in the food-tech and life sciences sectors.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Moolec Science SA (NASDAQ:MLEC) has entered a Share Purchase Agreement with Nomura Securities International, allowing the company to sell up to $50 million in ordinary shares over 36 months. This financing facility enhances Moolec's financial flexibility for its Molecular Farming initiatives. The proceeds will support general corporate purposes, helping advance the company's mission to produce animal proteins in plants. Moolec's innovative technology has a decade-long development history and focuses on sustainable food production, utilizing crops like safflower, soybean, and pea. Moolec currently holds 23 patents to strengthen its position in the alternative protein market.
For further details, refer to the Current Report on Form 6-K filed with the SEC.
Moolec Science SA (NASDAQ:MLEC) recently announced its acquisition of ValoraSoy, a strategic move aimed at enhancing its plant-based food ingredient capabilities for functional soy proteins. This $6 million transaction comprises approximately $2.5 million in cash and the remainder in shares, contingent upon performance metrics over three years. The acquisition equips Moolec with state-of-the-art processing facilities and a robust sales team, expanding its reach across more than 14 countries. The integration is expected to accelerate sales and generate estimated revenues of $6 million in the 2023/2024 period. Moolec aims to leverage its Molecular Farming platform to lower protein costs and improve product quality, addressing global food security challenges.